ATN biomarker classification system

Atn Biomarker Classification System enters the Adult Cognitive Disease corpus through the work of Martin Zhang (submission 117), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Martin Zhang's submission is summarised in this corpus as:

AD is a multi-level heterogeneous disease requiring an integrated perspective across molecular neuropathology, aging mechanisms, genetics, life exposures, and cellular/molecular mechanisms. The paper synthesizes evidence on amyloid-beta, tau, neuroinflammation, brain network impairment, epigenetics, and aging-related pathways including sirtuins and insulin/IGF1 signaling.

Where it sits

The submission scores against the framework's convergence nodes as: transcriptional / epigenetic 6 · neuroimmune interface 5 · ApoE4 hub 5 · compensatory paradigm 3 · endosomal nexus 2 · cytoskeletal collapse 2.

Its declared subject matter: multi-level-heterogeneity, integrated-perspective, epigenetics, sirtuins, neuroinflammation, brain-networks, aging, genetics.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Aging-epigenetic-genetic interaction · Integrated molecular-to-network perspective · Multi-level heterogeneity of AD.


Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.

Source: kb/wiki/concepts/ATN biomarker classification system.md